Troponin News and Research

RSS

Early discharge strategy for low-risk chest pain patients could lead to potential healthcare savings

A new evaluation to determine whether emergency room patients with chest pain can go home and follow up with their doctor proved 100% safe while shaving nearly a day off their visit and $6500 off their bill.

28 Sep 2017

Two protocols help assess patients with chest pain quickly and safely in emergency departments

Two protocols for quickly and safely evaluating patients presenting to emergency departments with chest pain are being adopted by Australian hospitals.

11 Sep 2017

Simple blood test could help identify patients at greater risk of cardiac event after orthopedic surgery

A new study published today in the HSS Journal, the leading journal on musculoskeletal research, found the incidence of myocardial ischemia (defined by an elevated troponin level) after major orthopedic surgery in patients with cardiac risk factors is high, although the incidence of serious cardiac complications remains low.

31 Jul 2017

Roche receives FDA clearance for new Troponin T test to detect patients with suspected heart attack

Roche announced that it has received the 510(k) clearance for its Elecsys Troponin T Gen 5 STAT (TnT Gen 5 STAT) blood test for patients with a suspected heart attack.

27 Jul 2017

Using quantum imaging to rule out cardiac conditions

In the UK, more than 5% of emergency department visits and up to 40% of emergency admissions are as a direct result of chest pain. Chest pain-related emergency hospital admissions not only create a vast economic burden on healthcare services but also cause huge disruption to inpatient care.

3 Jul 2017

Study shows how high-sensitivity assay improves evaluation for chest pain patients

For some time now, patients in Sweden's emergency clinics complaining of chest pain have been evaluated using the "high-sensitivity troponin T" assay. In a large-scale registry study published in the Journal of the American College of Cardiology scientists at Karolinska Institutet show how this more sensitive analytical method has improved evaluation for these patients.

30 May 2017

Troponin elevations can occur in the absence of classic myocardial infarction, study shows

Elevated cardiac troponin, a diagnostic marker of damage to the heart, may occur even if a patient has not had a heart attack, according to a study published in JACC: Basic to Translational Science.

9 May 2017

Five simple tests provide more accurate assessment of heart-disease risk

Five simple medical tests together provide a broader and more accurate assessment of heart-disease risk than currently used methods, cardiologists at UT Southwestern Medical Center found.

31 Mar 2017

Blood test can identify patients with heart injury after non-cardiac surgery

A blood test for a protein called high-sensitivity troponin T, which is released into the bloodstream when injury to the heart occurs, can identify patients with heart damage after non-cardiac surgery whose lives could potentially be saved with timely treatment, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.

20 Mar 2017

European hospital introduces Philips Minicare cTnI point-of-care blood test for rapid diagnosis of heart attack

Elkerliek Hospital (Helmond, the Netherlands) and Royal Philips, a leader in HealthTech, today announced their collaboration to pioneer the use of point-of-care testing in the hospital’s dedicated cardiac emergency department.

From Philips Healthcare 1 Mar 2017

OU study identifies numeracy as decision delay risk factor for individuals experiencing ACS

In a recent study to determine why some individuals who experience symptoms for acute coronary syndrome decide to seek medical attention more quickly than others, a University of Oklahoma researcher has identified numeracy -- the ability to understand and apply numerical concepts as the primary decision delay risk factor for individuals experiencing the medical condition.

28 Feb 2017

Bacterial infection detector by Philips awarded prize for better use of antibiotics

Philips and Diagnostics Development win European Union ‘Horizon Prize – Better Use of Antibiotics’ for the rapid detection of bacterial infection on Philips’ Minicare I-20 platform.

8 Feb 2017

New studies support secretoneurin as new biomarker for cardiovascular disease

Scandinavian cardiovascular diagnostics specialist CardiNor AS today announced two new studies have been published by the group at Akershus University Hospital led by Professor Torbjørn Omland and Associate Professor Helge Røsjø in leading journals that strongly support secretoneurin as a new, important biomarker for cardiovascular disease.

19 Oct 2016

Scientists develop mechanically stable, disposable sensor for monitoring heart attacks

Blood-glucose monitoring devices have revolutionized the management of diabetes by making it easy for ordinary individuals to test their glucose levels at home.

14 Oct 2016

Low levels of diastolic blood pressure linked to heart damage risk

By analyzing medical records gathered over three decades on more than 11,000 Americans participating in a federally funded study, researchers at Johns Hopkins Medicine say they have more evidence that driving diastolic blood pressure too low is associated with damage to heart tissue.

1 Sep 2016

Nurse-driven protocols can shorten length of stay for patients in emergency department

Protocols allowing nurses to administer certain types of treatment in the emergency department can dramatically shorten length of stay for patients with fever, chest pain, hip fractures and vaginal bleeding during pregnancy, according to the results of a study published earlier this month in Annals of Emergency Medicine.

26 Aug 2016

Philips to showcase advanced cardiology solutions at ESC Congress 2016

Royal Philips today announced its presence at the ESC Congress 2016, showcasing its latest in advanced integrated cardiology solutions with a focus on prevention, diagnosis and treatment.

26 Aug 2016

UK Export Award winner BBI Solutions to attend 2016 AACC

BBI Solutions, recent winners of the Made in the UK Export Award, will be attending the AACC Clinical Lab Expo in Philadelphia next month.

30 Jul 2016

Alnylam reports new results from investigational RNAi therapeutic programs

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today preliminary results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, both investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of hereditary TTR-mediated amyloidosis (hATTR amyloidosis).

6 Jul 2016

Cardiac troponin test refines ACS rule-out process

Testing high-sensitivity cardiac troponin T levels in patients with acute coronary syndromes reduces their need for cardiac stress testing and speeds their discharge from the emergency department, report researchers.

4 Jul 2016